Trial Characteristics as Contextual Factors when Evaluating Targeted Therapies in Patients with Psoriatic Disease: A Meta ‐Epidemiological Study

ConclusionFrom this exploratory meta‐epidemiological study we now have evidence from RCTs to support that patients with PsA are more likely to adhere to targeted therapies compared to patients with psoriasis. Furthermore, we identified a few contextual factors of importance in regard to achieving ACR20 in PsA trials and PASI75 in psoriasis trials.This article is protected by copyright. All rights reserved.

Source: Arthritis Care and Research - October 26, 2017 Category: Rheumatology Authors: Christine Ballegaard, Tanja S. J ørgensen, Marie Skougaard, Vibeke Strand, Philip J. Mease, Lars E. Kristensen, Lene Dreyer, Alice Gottlieb, Maarten de Wit, Robin Christensen, Simon Tarp Tags: Original Article Source Type: research